Medtronic (BSP:MDTC34) Retained Earnings: R$164,296 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
75 GF Score
Price R$52.47
GF Value R$62.02
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Retained Earnings?

Medtronic BSP:MDTC34 75 Retained Earnings is R$164,296 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 75/100 and a GF Value™ of R$62.02 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Medtronic's retained earnings for the quarter that ended in Apr. 2026 was R$164,296 Mil.

Medtronic's quarterly retained earnings declined from Oct. 2025 (R$172,639 Mil) to Jan. 2026 (R$172,227 Mil) and declined from Jan. 2026 (R$172,227 Mil) to Apr. 2026 (R$164,296 Mil).

Medtronic's annual retained earnings increased from Apr. 2024 (R$155,967 Mil) to Apr. 2025 (R$182,262 Mil) but then declined from Apr. 2025 (R$182,262 Mil) to Apr. 2026 (R$164,296 Mil).


Medtronic  (BSP:MDTC34) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Medtronic Retained Earnings Historical Data

* Premium members only.

The historical data trend for Medtronic's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Retained Earnings Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143,829.68 152,613.43 155,967.39 182,261.78 164,296.43

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 182,261.78 174,882.32 172,639.22 172,226.68 164,296.43
BSP:MDTC34
75GF Score
Medtronic PLC BSP:MDTC34
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of R$164,296 Mil mean?
Medtronic (BSP:MDTC34) has a Retained Earnings of R$164,296 Mil as of Apr. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Medtronic and its competitors.
Is Medtronic's Retained Earnings too high?
Medtronic's current Retained Earnings is R$164,296 Mil. Overall, Medtronic has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Retained Earnings compare to SYK and BSX?
Medtronic's Retained Earnings of R$164,296 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Medtronic and its competitors. Medtronic's current Retained Earnings is R$164,296 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$62.02, compared to a current price of R$52.47 — trading 15.4% below its estimated fair value. The current Retained Earnings is R$164,296 Mil. Medtronic's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Retained Earnings is R$164,296 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$52.47 is trading 15.4% below its estimated GF Value™ of R$62.02. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Retained Earnings: R$164,296 Mil
  • GF Value™: R$62.02 vs. price of R$52.47 (15.4% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
75GF Score

Get the complete analysis for BSP:MDTC34

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.47
Price
R$62.02
GF Value